Home > Insider Trading > Filing (0001209191-13-012411)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1108109	Community Health Systems Inc	CYH	Services-General Medical & Surgical Hospitals, Nec (8062)	133893191

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1217259	T Michael Portacci	4000 Meridian Boulevard Franklin TN 37067	Division President	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-02-27	20,167	$0.00	133,803	No	4	M	Direct
Common Stock	Disposition	2013-02-27	2,821	$41.71	130,982	No	4	F	Direct
Common Stock	Acquisiton	2013-02-27	30,000	$32.37	160,982	No	4	M	Direct
Common Stock	Disposition	2013-02-27	78,440	$41.30	82,542	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Performance Based Restricted	Disposition	2013-02-27	20,167	$0.00	20,167	$0.00
Common Stock	Stock Options (Right to Buy)	Disposition	2013-02-27	30,000	$0.00	30,000	$32.37
Common Stock	Performance Based Restricted	Acquisiton	2013-02-27	25,000	$0.00	25,000	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-02-16	2022-02-15	No	4	M	Direct
0	2006-02-28	2013-02-27	No	4	M	Direct
25,000	2014-02-27	2023-02-26	No	4	A	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Options (Right to Buy)	$38.30	2007-03-01	2016-02-29	20,000	20,000	Direct
Common Stock	Stock Options (Right to Buy)	$37.21	2008-02-28	2017-02-27	10,000	10,000	Direct
Common Stock	Stock Options (Right to Buy)	$40.41	2008-07-25	2017-07-24	100,000	100,000	Direct
Common Stock	Stock Options (Right to Buy)	$32.28	2009-02-27	2018-02-26	20,000	20,000	Direct
Common Stock	Stock Options (Right to Buy)	$33.90	2011-02-24	2020-02-23	10,000	10,000	Direct
Common Stock	Stock Options (Right to Buy)	$37.96	2012-02-23	2021-02-22	10,000	10,000	Direct
Common Stock	Stock Options (Right to Buy)	$21.07	2013-02-16	2022-02-15	8,000	8,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-02-29	20,000	20,000	Direct
2017-02-27	10,000	10,000	Direct
2017-07-24	100,000	100,000	Direct
2018-02-26	20,000	20,000	Direct
2020-02-23	10,000	10,000	Direct
2021-02-22	10,000	10,000	Direct
2022-02-15	8,000	8,000	Direct

Footnotes

Financial information necessary to determine if performance criteria had been satisfied was not publicly available on February 16, 2013, the first anniversary of the date of the award. At a meeting of the Compensation Committee ("Committee") held February 26, 2013, and confirmed by the Board of Directors ("Board") on February 27, 2013, the Committee and the Board determined that the performance conditions had been satisfied. The shares will now be reported as owned shares in Table I, and restrictions on the remaining shares will lapse on the 2nd and 3rd anniversary of the original date of the award, all in accordance with the award agreement.
The shares were sold in a series of transactions at a weighted average price of $41.3011 per share.
Each performance based restricted share represents a contingent right to receive one share of CYH common stock. There are two elements to the lapsing of the restriction; first, the Company must achieve specified targeted amount of earnings per share from continuing operations, or net revenue from continuing operations, and if the performance objective is met, the vesting restrictions will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. If the objectives are not met, the shares will be forfeited.